by Manon Oliero
Around one in four patients with IBD may continue to experience IBS-like symptoms despite objectively documented remission. A new international consensus provides clinicians with a framework for recognizing and managing this challenging clinical picture.
by Manon Oliero, Giovana Martucelli, Andreu Prados
The 14th edition of the Gut Microbiota for Health World Summit brought together leading researchers from around the world to present the latest advances in the field. The meeting reinforced clinical practices that have become increasingly established in recent years and also presented unpublished results on new microbiome-targeted therapies, in line with the summit’s central theme: “Diet and other ways to manipulate the gut microbiome in clinical practice.”
by Andreu Prados
Many patients with IBS find that wheat or gluten triggers gastrointestinal symptoms, prompting them to exclude these foods from their diets. A new study highlights how patients’ expectations and beliefs shape symptom modulation and dietary choices in IBS.
Scientists are starting to elucidate the roots of gastrointestinal symptoms that appear after a meal in people with irritable bowel syndrome. Current research highlights the immune drivers of gut pain, which could offer clues on how to treat IBS.
The fourth edition of IBS Days covered the latest IBS diagnosis and treatment advances in a postgraduate course. Read about the highlights and discussions (part 2).
by Andreu Prados
June 17-19 2024, Gut Microbiota for Health attended the fourth edition of IBS Days 2024 in Bologna, Italy, alongside 400 in-person attendees. Find out more about the most relevant basic, translational, and clinical science highlights in IBS (part 1).
by Premysl Bercik, Andreu Prados
While the idea that our gut can influence our brain is not new, this is a rapidly growing area of research. Find out more on how gut microbes influence anxiety and stress and why tackling these psychological traits matters for irritable bowel syndrome.
by Andreu Prados, Kate Scarlata
Food is considered the main trigger of digestive symptoms in the vast majority of patients living with IBS. While finding foods that do not prompt gastrointestinal (GI) symptoms has been a challenge for many people with IBS, restrictive diets can come with potential risks. Learn more about diets with evidence in IBS.
by Andrea Costantino
Chronic abdominal pain, diarrhea, constipation, and bloating are common gastrointestinal symptoms. While a structural or an organic disease can be suspected because of the symptoms and is often easy to be diagnosed by endoscopy or imaging methods, sometimes gastrointestinal symptoms are not related to any alteration that may be seen through diagnostic techniques, and consequently have been classified under the umbrella of “disorders of gut-brain interaction”.
by GMFH Editing Team
Dr. James Versalovic updates what we know so far about the contribution of an altered gut microbiota to the development of the IBS and the available science-backed tools for relieving symptoms.
